Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-26

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for pramipexole dihydrochloride from Torrent Pharmaceuticals Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)